Aspirin does not reduce heart attacks with diabetes

The investigators who conducted this meta-analysis published in the British Medical Journal selected 6 eligible studies comprising 10,117 participants with diabetes and found: "When aspirin was compared with placebo there was no statistically significant reduction in the risk of major cardiovascular events...A clear benefit of aspirin in the primary prevention of major cardiovascular events in people with diabetes remains unproved. Sex may be an important effect modifier." Some benefit was found for men (none for women) but "the expected benefits might not exceed the risk of major bleedings....We cannot recommend using aspirin in the primary prevention of cardiovascular events in all patients with diabetes without additional evidence..."